Question 1

What is a CRDMO?

Accepted Answer

A CRDMO (Contract Research, Development & Manufacturing Organisation) helps pharmaceutical and biotechnology companies take a product from early research to commercial manufacturing. Instead of working with multiple vendors, companies can access research, development, manufacturing, quality and regulatory support through one integrated partner.

Question 2

What does a CRDMO do?

Accepted Answer

A CRDMO supports every stage of the product journey - from research and process development to analytical testing, GMP manufacturing, quality assurance and regulatory support. By bringing these services together, a CRDMO helps companies develop products faster and more efficiently.

Question 3

What's the difference between a CRO, CDMO and CRDMO?

Accepted Answer

A CRO focuses on research and clinical studies. A CDMO specialises in development and manufacturing. A CRDMO combines research, development and manufacturing in one integrated model, making it easier to move from discovery to commercial production.

Question 4

Why do pharmaceutical companies use a CRDMO?

Accepted Answer

Developing a new therapy takes specialised expertise, advanced infrastructure and significant investment. Working with a CRDMO gives pharmaceutical and biotech companies access to experienced scientists, GMP facilities and regulatory support - helping reduce costs, shorten timelines and speed up product development.

Question 5

Who can benefit from CRDMO services?

Accepted Answer

CRDMO services are used by pharmaceutical companies, biotechnology firms, cell and gene therapy developers, biologics companies, research institutes, healthcare organisations and startups looking to develop and manufacture innovative therapies.

Question 6

When should a company partner with a CRDMO?

Accepted Answer

Some companies work with a CRDMO from the very beginning of product development, while others partner when they're ready to scale manufacturing, transfer technology or prepare for regulatory approval. It really depends on where your product is in its development journey.

Question 7

Can Global CRDMO support both development and manufacturing?

Accepted Answer

Yes. Through our global partner network, we help coordinate research, process development, analytical testing, GMP manufacturing, quality management and regulatory support - making the transition from discovery to commercial production much smoother.

Question 8

Do you support biologics and advanced therapies?

Accepted Answer

Yes. Our network supports biologics, biosimilars, pharmaceuticals, cell and gene therapies (CGT) and other advanced therapeutics that require specialised development and manufacturing capabilities.

Question 9

Can you help with technology transfer?

Accepted Answer

Absolutely. We help coordinate technology transfer between research laboratories and manufacturing facilities, ensuring processes can be scaled efficiently while maintaining product quality and consistency.

Question 10

Can you help with regulatory submissions?

Accepted Answer

Yes. We work with experienced regulatory specialists who support documentation, compliance planning, quality systems and submission strategies for major international regulatory markets.

Question 11

Do you provide GMP manufacturing?

Accepted Answer

Yes. Through our trusted global network, we connect clients with GMP-compliant manufacturing facilities that meet international quality and regulatory standards.

Question 12

Do you work with startups as well as large pharmaceutical companies?

Accepted Answer

Yes. Whether you're an early-stage biotech startup, an academic research team or an established pharmaceutical company, we tailor our support to your stage of development and project goals.

Question 13

Can Global CanCare coordinate multiple CRDMO partners?

Accepted Answer

Yes. Many CRDMO projects involve research labs, manufacturing facilities, quality teams and regulatory experts across different locations. We act as a single point of coordination, helping simplify communication and keep projects moving forward.

Question 14

Do you only work with organisations in India?

Accepted Answer

No. Global CRDMO supports pharmaceutical, biotechnology and healthcare organisations worldwide through an international network of specialist partners, technologies and manufacturing capabilities.

Question 15

How does a CRDMO help bring products to market faster?

Accepted Answer

By bringing research, development, manufacturing and regulatory support together, a CRDMO reduces handoffs between vendors, simplifies project management and helps products move more quickly toward clinical and commercial milestones.

Question 16

Why choose Global CanCare's CRDMO network?

Accepted Answer

Global CanCare gives you access to a carefully selected network of research organisations, GMP manufacturing facilities, quality experts and regulatory specialists - all coordinated through a single trusted partner. That means less complexity, greater flexibility and faster progress from concept to commercialisation.

Accelerating Healthcare
Innovation from Discovery
to Commercialisation

Contract Research, Development & Manufacturing Solutions

Your Partner Across the Product Development Journey

The Growing Demand for Integrated CRDMO Partnerships

Market by 2034

Outsourcing Rate

Integrated Partnerships

End-to-End CRDMO Services

Clinical Research

Contract Development

Contract Manufacturing

Regulatory Support

Commercial Manufacturing

Technology Transfer

Quality & Compliance

Built Around Partnership, Quality & Scale

CRDMO FAQs

Continue Exploring the Ecosystem

Let's build the future of
Cancer Care together

Accelerating Healthcare Innovation from Discovery to Commercialisation